Differential diagnosis of Crohn's disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

DUMAN A. E., HÜLAGÜ S., ÇELEBİ A., Korkmaz U., Musul M. M., Senturk O., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.1, pp.21-27, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2018.18135
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.21-27
  • Kocaeli University Affiliated: Yes

Abstract

Background/Aims: Glycoprotein 2 (GP2), the major autoantigen of Crohn's disease (CD)-specific pancreatic autoantibodies, is reportedly correlated with several characteristics of CD. We investigated this serological marker in Turkish patients with CD and assessed its utility in combination with anti-Saccharomyces cerevisiae antibodies (ASCAs) for differential diagnosis of CD.